In conclusion, all six meta-analyses showed statistically significant SMD (p < 0.0001) and reported values for the Aβ(1-42)/P-tau ratio indicated this as the most robust indicator of a patient transitioning from MCI to AD. Here, MAPT is linked to Alzheimer disease.